Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文（繁體）
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Language
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Anti-OX40Ligand treatment as a...
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Permanent link
Anti-OX40Ligand treatment as a novel therapeutic strategy in a murine model of colitis
Bibliographic Details
Main Authors:
Singh, B
,
Malmstrom, V
,
Powrie, F
Format:
Journal article
Published:
2001
Holdings
Description
Similar Items
Staff View
Similar Items
OX40 is required for regulatory T cell-mediated control of colitis.
by: Griseri, T, et al.
Published: (2010)
Anti-interleukin 12 antibody prevents colitis in a murine T cell transfer model of inflammatory bowel disease
by: Singh, B, et al.
Published: (2003)
OX40 is differentially expressed on activated rat and mouse T cells and is the sole receptor for the OX40 ligand.
by: al-Shamkhani, A, et al.
Published: (1996)
The role of T cell subsets in hepatic inflammation in the scid model of colitis
by: Singh, B, et al.
Published: (1999)
OX40L blockade is therapeutic in arthritis, despite promoting osteoclastogenesis.
by: Gwyer Findlay, E, et al.
Published: (2014)